Pfizer to acquire sickle cell drugmaker GBT for $5 bn
American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion.
Aug 8, 2022
0
3
American drugmaker Pfizer announced a deal on Monday to acquire Global Blood Therapeutics, makers of a recently approved treatment for sickle cell disease, for $5.4 billion.
Aug 8, 2022
0
3
American drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Aug 7, 2022
0
4
Seventy five percent of movies earn a net loss during their run in theaters. A new study in the Journal of Marketing Research finds that brain activity visible through EEG measures may be a much cheaper and more accurate ...
Feb 25, 2015
0
74
The Obama administration says consumers in most states will have more insurance options next year under the president's health care law.
Sep 23, 2014
0
0
India's biggest generic drugmaker Ranbaxy Laboratories swung into a net loss in the third quarter ended September from a profit a year earlier, owing to a weak rupee and foreign exchange losses.
Oct 29, 2013
0
0
(AP) -- Bill Gates pledged $750 million on Thursday to fight three killer diseases and rescue a beleaguered health fund whose financial losses have cost it donor support.
Jan 26, 2012
0
0